Podcast Summary
Podcast Summary for S2E4: Thalassaemia Carriers: it’s not as simple as just being “anaemic.”
Yoyo Chu
·
Full episode is available here (in Cantonese).
<div id="buzzsprout-player-19258242"></div><script src="https://www.buzzsprout.com/2552094/episodes/19258242-s2e4.js?container_id=buzzsprout-player-19258242&player=small" type="text/javascript" charset="utf-8"></script>
Where It All Begins: A Common Misconception
This episode of Gene Talk is hosted by Yoyo, a genetic counsellor based in Hong Kong.
The episode opens with a real-life case: Shanshan, a thirty-year-old newlywed planning her first pregnancy, walks into the consultation room with an old health check report.
The report indicates mild anaemia, with a note suggesting she may be a thalassaemia carrier.
Her immediate reaction is: “Can’t I just take more iron?” — a question that captures a widespread misconception and becomes the central thread of the entire episode.
Thalassaemia and Iron Deficiency Anaemia Are Two Entirely Different Conditions
Although both fall under the umbrella term “anaemia,” the two conditions have fundamentally different causes.
Iron deficiency anaemia occurs when the body lacks the raw material — iron — needed to produce red blood cells. Replenishing iron resolves the problem.
Thalassaemia is caused by a genetic mutation. The body’s “instruction manual” for producing haemoglobin contains an error, meaning it cannot produce normal haemoglobin regardless of how much iron is available.
Iron supplementation is not only ineffective for thalassaemia — for those with major forms of the condition, excess iron accumulates in the heart and liver, causing serious organ damage.
Alpha or Beta? Understanding Your Genetic Identity
Thalassaemia is broadly classified into two types: Alpha thalassaemia and Beta thalassaemia, depending on which protein chain in the haemoglobin molecule is affected.
In Hong Kong, Alpha thalassaemia is more prevalent, while Beta thalassaemia is less common — but both carry the same implications for family planning.
In terms of severity, thalassaemia is further divided into minor, intermedia, and major forms.
Most people who discover they “have thalassaemia” fall into the minor category, commonly referred to as carriers. Carriers typically experience minimal anaemia or no symptoms at all, and their daily lives, work, and exercise are largely unaffected.
The Critical 25%: When Two Carriers Meet
The issue is not with carriers themselves — it is with what happens when two carriers of the same type meet.
When both partners carry the same type of thalassaemia, every pregnancy carries three possible outcomes:
A one-in-four chance that the baby is completely unaffected.
A one-in-two chance that the baby is a carrier, similar to the parents, with no significant health impact.
A one-in-four chance that the baby inherits a faulty gene from both parents, resulting in thalassaemia major.
This is not a remote possibility — it is a straightforward matter of genetics.
Many couples only discover that both are carriers at the stage of prenatal testing, leaving them far less time and space to consider their options calmly.
The Reality of Thalassaemia Major and the Latest in Gene Therapy
Patients with thalassaemia major are unable to produce sufficient normal haemoglobin from infancy, requiring lifelong regular blood transfusions approximately every three to four weeks.
Long-term transfusions lead to iron overload in the body, damaging the heart and liver, so patients must also take iron chelation medication indefinitely.
This represents an enormous and unrelenting burden — physically, emotionally, and financially — for both the patient and the entire family.
In recent years, gene therapy has offered new hope for patients with severe Beta thalassaemia. The approach involves extracting a patient’s own haematopoietic stem cells, correcting the genetic defect in the laboratory, and reinfusing the cells into the body.
If successful, patients may be freed from the need for lifelong blood transfusions.
However, this treatment is currently not registered in Hong Kong and must be carried out at specialist medical centres overseas, with costs running into tens of millions of Hong Kong dollars.
Treatment timing is also critical — it is generally most effective before significant organ damage has occurred.
If You Suspect You May Be a Carrier: Three Practical Steps
Step 1 — Seek confirmation. If your health check report indicates mild anaemia or a possible thalassaemia trait, ask your doctor to arrange a Haemoglobin Electrophoresis test and, where appropriate, genetic testing to confirm your carrier status and identify the specific type.
Step 2 — Invite your partner to be screened. Only by combining both sets of results can you gain a full picture of your family’s genetic landscape — one person’s report tells only half the story.
Step 3 — Attend a genetic counselling session. Bring both reports and let a genetic counsellor walk you through all available pathways, whether that involves natural conception combined with prenatal diagnosis, or Preimplantation Genetic Testing for Monogenic disorders (PGT-M).
The Core Message from a Genetic Counsellor
“The question is not whether you are a carrier — it is whether you know you are one.” Knowing is where choice begins.
Genetic counselling is not about magnifying fear. It is about providing a clear map, so that every couple can make the most informed and considered decisions for themselves and their future children, with time on their side.
Next episode: Would AI Replace Genetic Counsellors?
GENE TALKS Podcast Disclaimer
The content of this podcast is provided for general educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment of any kind.
If you have questions about your personal health, genetic test results, or medical decisions, you should consult a qualified healthcare or genetics professional.
Any cases, experiences, or opinions mentioned in this program reflect the personal views of the host, and do not represent the positions of any medical institutions or professional organisations.
While GENE TALKS and its host endeavor to provide accurate and reliable information, they are not responsible for any consequences arising from the use or interpretation of the content.
Our mission: to help you understand genetics — and yourself — not to replace professional judgment.